John Aballi

Decipher Biosciences, Inc. is a commercial-stage precision oncology company which engages in patient care improvement. The Company?s differentiated approach measures the biological activity of a patient?s entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to improve therapy selection and accelerate adoption of new therapies into the standard of care. Its novel prostate cancer genomic testing products examine the underlying biology of a patient?s tumor, enabling physicians to select an optimal therapy. The firm?s whole transcriptome analysis of clinical patient samples from its commercial channel and its participation in practice-changing clinical trials has allowed it to build and expand its Decipher GRID database GRID. The company was founded by Elai Davicioni, Timothy J. Triche, Bruce A. Schmidt, and Jonathan D. Buckley and is headquartered in San Diego, CA.

PFS Genomics, Inc. provides radiation therapy for breast cancer treatment. The company was founded by Lori J. Pierce, Felix Y. Feng and Corey W. Speers and is headquartered in Vancouver, Canada.

Molecular Stethoscope, Inc. provides molecular diagnostics services. It offers novel blood-based early detection and disease monitoring tests to detect liver, coronary artery, inflammatory, neurodegenerative, coronary artery, autoimmune and inflammatory diseases. The company was founded by Stephen D. Phil Quake and Eric J. Topol on September 1, 2015 and is headquartered in San Diego, CA.

Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA.